RTI Surgical Reaches Global Milestone of Providing 8 Million Biologic Implants with Zero Confirmed Incidence of Implant-Assoc...
April 04 2018 - 7:00AM
Business Wire
RTI celebrates 20-year anniversary of providing
safe, high-quality surgical implants
RTI Surgical, Inc. (Nasdaq: RTIX), a global provider of surgical
implants, celebrates a significant global milestone of providing
more than 8 million biologic implants processed through RTI’s
proprietary sterilization processes with zero confirmed incidence
of implant-associated infection. In 2017 alone, RTI distributed
more than 600,000 biologic implants—helping surgeons serve patients
in nearly 50 countries.
RTI celebrates these milestones and marks its 20th anniversary
of delivering trusted surgical implants during National Donate Life
Month in April. RTI has a proud, 20-year history of “firsts” in
biologic surgical implants. It is recognized for initiating and
elevating standards for the tissue banking industry, including
being the first to introduce tissue-specific validated
sterilization processes — the BioCleanse® Tissue Sterilization
Process, the Cancelle® SP DBM Sterilization Process and the
Tutoplast® Tissue Sterilization Process. It was also the first to
offer precision-shaped bone implants and assembled technologies.
Our world-class facilities in the U.S. and Europe provide a
combined 250,000+ square feet of manufacturing for these advanced
technologies.
“For 20 years, RTI has led the way in tissue safety for biologic
implants in our industry, always keeping the patient in mind,” said
Camille Farhat, President and CEO, RTI Surgical. “Our commitment to
tissue safety is evident by our redundant safeguards and
proprietary, validated sterilization processes, allowing us to
achieve more than 8 million biologic implants with zero confirmed
incidence of implant-associated infection. We celebrate these
milestones in honor of the healthcare professionals and patients we
serve globally and with appreciation for the gifts of life that
make such healing and restoration possible.”
RTI’s tissue-based implants are used in surgical procedures such
as anterior cruciate ligament reconstruction, meniscus
transplantation, fracture repair, rotator cuff repair, wound
coverings, post-mastectomy breast reconstruction and abdominal wall
repair for hernias.
“RTI Surgical continues to raise the bar as a trusted provider
of patient-centered biologic solutions with a proven track record
for advancing science, safety and innovation,” said Peter
Indelicato, M.D., professor emeritus and physician with the
University of Florida Department of Orthopaedics and
Rehabilitation’s Sports Medicine, Orthopaedics and Sports Surgery
division. Dr. Indelicato has been a consultant with RTI since its
inception. “RTI was instrumental in developing groundbreaking
sterilization technology with proven effectiveness and safety, such
as BioCleanse, and continues to drive innovation today with its
portfolio of biologic implants. As the former Head Team Physician
for the University of Florida Gator football team, I often relied
on RTI implants to help restore our athletes to health.”
Ryanne Wilkes is a labor and delivery nurse and one among the
millions of patients whose lives have been restored by receiving an
RTI biologic implant. “I do not think I could have made it as far
in my nursing career with my hip in the awful shape it was in,”
Ryanne said. “The gift of donated tissue and the biologic implant
created from that gift changed my life and will also touch the
lives of the many patients I care for throughout my career.”
RTI joins Donate Life America in celebrating National Donate
Life Month and encouraging Americans to save and restore lives by
registering as organ, eye and tissue donors at
www.registerme.org.
About RTI Surgical, Inc.
RTI Surgical is a leading global surgical implant company
providing surgeons with safe biologic, metal and synthetic
implants. Committed to delivering a higher standard, RTI’s implants
are used in sports medicine, general surgery, spine, orthopedic,
trauma and cardiothoracic procedures and are distributed in nearly
50 countries. RTI has four manufacturing facilities throughout the
U.S. and Europe. RTI is accredited in the U.S. by the American
Association of Tissue Banks and is a member of AdvaMed. For more
information, please visit www.rtix.com.
Forward-Looking Statements
This communication contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. These forward-looking statements are based on management’s
current expectations, estimates and projections about our industry,
our management's beliefs and certain assumptions made by our
management. Words such as "anticipates," "expects," "intends,"
"plans," "believes," "seeks," "estimates," variations of such words
and similar expressions are intended to identify such
forward-looking statements. In addition, except for historical
information, any statements made in this communication about
anticipated financial results, growth rates, new product
introductions, future operational improvements, gaining market
share and results or regulatory actions or approvals or changes to
agreements with distributors also are forward-looking statements.
These statements are not guarantees of future performance and are
subject to risks and uncertainties, including the risks described
in public filings with the U.S. Securities and Exchange Commission
(SEC). Our actual results may differ materially from the
anticipated results reflected in these forward-looking statements.
Copies of the company's SEC filings may be obtained by contacting
the company or the SEC or by visiting RTI's website at www.rtix.com
or the SEC's website at www.sec.gov.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180404005288/en/
RTI Surgical, Inc.Media ContactsErin Morton,
+1-352-519-8351emorton@rtix.comorMolly Poarch,
+1-224-287-2661mpoarch@rtix.comorInvestor ContactNathan
Elwell, +1-847-530-0249nelwell@lincolnchurchilladvisors.com
RTI Surgical (NASDAQ:RTIX)
Historical Stock Chart
From Aug 2024 to Sep 2024
RTI Surgical (NASDAQ:RTIX)
Historical Stock Chart
From Sep 2023 to Sep 2024